HPS Pharmacies wish to give notice that Alphapharm is experiencing a supply interruption for Zedace® as follows:
This supply interruption is due to the recent discontinuation of Capoten® and Captopril Sandoz®. Zedace® is now the only brand of captopril marketed in Australia. Normal supplies of Zedace® 50mg are expected to resume in September 2020, while Zedace® 25mg is likely to experience supply volatility throughout this period.
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact Alphapharm on 1800 274 276 or your pharmacist at HPS Pharmacies.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates